Eqis Capital Management, Inc. Selecta Biosciences Inc Transaction History

Eqis Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.96 - $1.6 $1,145 - $1,908	-1,193 Reduced 5.32%	21,225 $23,000
Q3 2022 Oct 24, 2022	SELL	$1.33 - $2.6 $1,130 - $2,210	-850 Reduced 3.65%	22,418 $0
Q2 2022 Aug 08, 2022	SELL	$0.67 - $1.4 $725 - $1,516	-1,083 Reduced 4.45%	23,268 $30,000
Q1 2022 May 16, 2022	BUY	$1.23 - $3.31 $29,951 - $80,601	24,351 New	24,351 $30,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.